Novartis AG (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 154   

Articles published

NVS 74.19 -0.14 (-0.19%)
price chart
Pfizer Inc, Sanofi SA (ADR), Novartis AG (ADR): Who Will Acquire Medivation Inc?
As the merger and acquisition (M&A) spree is booming, multiple pharmaceutical companies have put Medivation Inc. (NASDAQ:MDVN) on the top of their acquisition list.
Earnings per Share Report: Novartis AG (ADR) (NYSE:NVS)
Last Trade: The Company fell -2.34% and finished at $74.33. The daily volume was measured at 2.17 million shares. The 52-week high of the share price is $106.84 and the 52-week low is $69.89.
Novartis AG (ADR) (NYSE:NVS) To Pay $25 Million Over Bribery Allegations
Last year GlaxoSmithKline plc (ADR) (NYSE:GSK) posted a 17% drop in sales as a state-led campaign on drug prices affected returns.
Novartis AG (ADR) (NYSE:NVS): Big Market Mover
[Market Realist] Novartis AG (ADR) (NYSE:NVS)(TREND ANALYSIS) reported a rise of ~1% in its revenue on a constant currency basis in its 1Q16 earnings.
Novartis AG (ADR) Under Pressure on Q1 Revenue Decline
Novartis AG (ADR) (NYSE:NVS) has reported financial results for the first quarter of fiscal year 2016 (1QFY16) with a decline in both, its earnings and revenues.
Bimagrumab (BYM338) drug from Novartis AG (ADR) (NYSE:NVS) Failed a Phase IIb ...
Bimagrumab (BYM338) from Novartis AG (ADR) (NYSE:NVS) failed a Phase IIb/III study. The news of the failure of the study pertaining to a rare, muscle-wasting disease known as sporadic inclusion body myositis was heartbreaking for the pharma giant since ...
Analysts Review: Novartis AG (ADR) (NYSE:NVS)
Novartis AG (ADR) (NYSE:NVS) received “Downgrade” rating by Morgan Stanley in a research note issued to investors on Apr-12-16 from Equal-Weight to Underweight.
Why Novartis AG (ADR) have been downgraded?  CWRU Observer
Insiders Are Buying These Shares: Novartis AG (ADR) (NYSE:NVS), Consolidated ...  iStreetWire
Novartis AG (ADR) First-Quarter Earnings: What to Expect?
Novartis AG (ADR) (NYSE:NVS) is set to announce its financial results for the first quarter of 2016 (1Q) on Thursday, April 21.
Novartis AG (ADR) (NYSE:NVS) Sells 14 Drug Brands Worth $293 Million To Sun In ...
Novartis AG (ADR) (NYSE:NVS) has sold more than a dozen drugs to India's Sun Pharmaceutical in Japan. The development follows a trend that has become popular among major pharmaceutical companies.
Novartis AG (NVS) Rating Lowered to Neutral at Citigroup Inc.  South Florida Hedge Fund Managers
Novartis Is Under SEC Investigation, Probes Reporter Says  Benzinga
HC Stocks Reports Analysis: Novartis AG (ADR) (NVS), Pfizer Inc. (PFE), Sanofi ...
Shares of Novartis AG (ADR) (NYSE:NVS) ended Thursday session in red amid volatile trading. The shares closed down -0.17 points or -0.22% at $76.81 with 2.26M shares getting traded.